{"count": 24, "results": [{"_id": "34588803", "pmid": 34588803, "pmcid": "PMC8473846", "title": "Retarding Progression of Chronic Kidney Disease in Autosomal Dominant Polycystic Kidney Disease with Metformin and Other Therapies: An Update of New Insights", "journal": "Int J Gen Med", "authors": ["Carullo N", "Zicarelli MT", "Casarella A", "Nicotera R", "Castagna A", "Urso A", "Presta P", "Andreucci M", "Russo E", "Bolignano D", "Coppolino G"], "date": "2021-09-22T00:00:00Z", "doi": "10.2147/IJGM.S305491", "meta_date_publication": "2021", "meta_volume": "14", "meta_issue": "", "meta_pages": "5993-6000", "score": 50273.79, "text_hl": "Takiar et al have noticed that in the renal parenchyma of @SPECIES_10090 @@@mouses@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @<m>DISEASE_Cysts</m> @DISEASE_MESH:D003560 @@@cysts@@@ persist; this proves the inability of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to revert cystogenesis when the @<m>DISEASE_Cysts</m> @DISEASE_MESH:D003560 @@@cysts@@@ have already been produced. ", "citations": {"NLM": "Carullo N, Zicarelli MT, Casarella A, Nicotera R, Castagna A, Urso A, Presta P, Andreucci M, Russo E, Bolignano D, Coppolino G. Retarding Progression of Chronic Kidney Disease in Autosomal Dominant Polycystic Kidney Disease with Metformin and Other Therapies: An Update of New Insights Int J Gen Med. 2021;14():5993-6000. PMID: 34588803", "BibTeX": "@article{34588803, title={Retarding Progression of Chronic Kidney Disease in Autosomal Dominant Polycystic Kidney Disease with Metformin and Other Therapies: An Update of New Insights}, author={Carullo N and Zicarelli MT and Casarella A and Nicotera R and Castagna A and Urso A and Presta P and Andreucci M and Russo E and Bolignano D and Coppolino G}, journal={Int J Gen Med}, volume={14}, pages={5993-6000}}"}}, {"_id": "34957500", "pmid": 34957500, "title": "Metformin induces lactate accumulation and accelerates renal cyst progression in Pkd1-deficient mice.", "journal": "Hum Mol Genet", "authors": ["Chang MY", "Tsai CY", "Chou LF", "Hsu SH", "Yang HY", "Hung CC", "Tian YC", "Ong ACM", "Yang CW"], "date": "2022-05-19T00:00:00Z", "doi": "10.1093/hmg/ddab340", "meta_date_publication": "2022 May 19", "meta_volume": "31", "meta_issue": "10", "meta_pages": "1560-1573", "score": 50258.477, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ induces @CHEMICAL_Lactic_Acid @CHEMICAL_MESH:D019344 @@@lactate@@@ accumulation and accelerates @<m>DISEASE_Cysts</m> @DISEASE_MESH:D003560 @@@renal cyst@@@ progression in @GENE_PKD1 @GENE_18763 @@@Pkd1@@@-deficient @SPECIES_10090 @@@mice@@@.", "citations": {"NLM": "Chang MY, Tsai CY, Chou LF, Hsu SH, Yang HY, Hung CC, Tian YC, Ong ACM, Yang CW. Metformin induces lactate accumulation and accelerates renal cyst progression in Pkd1-deficient mice. Hum Mol Genet. 2022 May 19;31(10):1560-1573. PMID: 34957500", "BibTeX": "@article{34957500, title={Metformin induces lactate accumulation and accelerates renal cyst progression in Pkd1-deficient mice.}, author={Chang MY and Tsai CY and Chou LF and Hsu SH and Yang HY and Hung CC and Tian YC and Ong ACM and Yang CW}, journal={Hum Mol Genet}, volume={31}, number={10}, pages={1560-1573}}"}}, {"_id": "35182540", "pmid": 35182540, "title": "Proliferative cells in racemose neurocysticercosis have an active MAPK signalling pathway and respond to metformin treatment.", "journal": "Int J Parasitol", "authors": ["Orrego MA", "Verastegui MR", "Vasquez CM", "Garcia HH", "Nash TE", "Cysticercosis Working Group in Peru"], "date": "2022-05-01T00:00:00Z", "doi": "10.1016/j.ijpara.2022.01.001", "meta_date_publication": "2022 May", "meta_volume": "52", "meta_issue": "6", "meta_pages": "377-383", "score": 50253.527, "text_hl": "Our findings indicate the importance of @GENE_INSR @GENE_16337 @@@insulin receptor@@@-mediated activation of the MAPK signalling pathway in the proliferation and growth of the bladder wall of the @<m>DISEASE_Cysts</m> @DISEASE_MESH:D003560 @@@racemose cyst@@@ and its susceptibility to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ action. ", "citations": {"NLM": "Orrego MA, Verastegui MR, Vasquez CM, Garcia HH, Nash TE, Cysticercosis Working Group in Peru. Proliferative cells in racemose neurocysticercosis have an active MAPK signalling pathway and respond to metformin treatment. Int J Parasitol. 2022 May;52(6):377-383. PMID: 35182540", "BibTeX": "@article{35182540, title={Proliferative cells in racemose neurocysticercosis have an active MAPK signalling pathway and respond to metformin treatment.}, author={Orrego MA and Verastegui MR and Vasquez CM and Garcia HH and Nash TE and Cysticercosis Working Group in Peru}, journal={Int J Parasitol}, volume={52}, number={6}, pages={377-383}}"}}, {"_id": "36660586", "pmid": 36660586, "title": "Combining Metformin and Drug-Loaded Kidney-Targeting Micelles for Polycystic Kidney Disease.", "journal": "Cell Mol Bioeng", "authors": ["Jiang K", "Huang Y", "Chung EJ"], "date": "2022-12-22T00:00:00Z", "doi": "10.1007/s12195-022-00753-9", "meta_date_publication": "2023 Feb", "meta_volume": "16", "meta_issue": "1", "meta_pages": "55-67", "score": 50250.11, "text_hl": "Results: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ combined with all drug-loaded KMs demonstrated significantly enhanced efficacy as compared to free drugs in inhibiting cell proliferation and @<m>DISEASE_Cysts</m> @DISEASE_MESH:D003560 @@@cyst@@@ growth. ", "citations": {"NLM": "Jiang K, Huang Y, Chung EJ. Combining Metformin and Drug-Loaded Kidney-Targeting Micelles for Polycystic Kidney Disease. Cell Mol Bioeng. 2023 Feb;16(1):55-67. PMID: 36660586", "BibTeX": "@article{36660586, title={Combining Metformin and Drug-Loaded Kidney-Targeting Micelles for Polycystic Kidney Disease.}, author={Jiang K and Huang Y and Chung EJ}, journal={Cell Mol Bioeng}, volume={16}, number={1}, pages={55-67}}"}}, {"_id": "33127449", "pmid": 33127449, "title": "Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease.", "journal": "J Control Release", "authors": ["Wang J", "Chin D", "Poon C", "Mancino V", "Pham J", "Li H", "Ho PY", "Hallows KR", "Chung EJ"], "date": "2021-01-10T00:00:00Z", "doi": "10.1016/j.jconrel.2020.10.047", "meta_date_publication": "2021 Jan 10", "meta_volume": "329", "meta_issue": "", "meta_pages": "1198-1209", "score": 50246.875, "text_hl": "To test its utility for @DISEASE_Chronic_Disease @DISEASE_MESH:D002908 @@@chronic diseases@@@ such as @DISEASE_Polycystic_Kidney_Diseases @DISEASE_MESH:D007690 @@@PKD@@@, we loaded the candidate @DISEASE_Polycystic_Kidney_Diseases @DISEASE_MESH:D007690 @@@PKD@@@ drug, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, into @CHEMICAL_Chitosan @CHEMICAL_MESH:D048271 @@@chitosan@@@ nanoparticles, and upon oral administration to a @DISEASE_Polycystic_Kidney_Diseases @DISEASE_MESH:D007690 @@@PKD@@@ @SPECIES_10090 @@@murine@@@ model (Pkd1fl/fl;Pax8-rtTA;Tet-O cre), a lower @<m>DISEASE_Cysts</m> @DISEASE_MESH:D003560 @@@cyst@@@ burden was observed compared to free @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and was well tolerated upon repeated dosages. ", "citations": {"NLM": "Wang J, Chin D, Poon C, Mancino V, Pham J, Li H, Ho PY, Hallows KR, Chung EJ. Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease. J Control Release. 2021 Jan 10;329():1198-1209. PMID: 33127449", "BibTeX": "@article{33127449, title={Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease.}, author={Wang J and Chin D and Poon C and Mancino V and Pham J and Li H and Ho PY and Hallows KR and Chung EJ}, journal={J Control Release}, volume={329}, pages={1198-1209}}"}}, {"_id": "34328226", "pmid": 34328226, "title": "Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease.", "journal": "Med Res Rev", "authors": ["Casarella A", "Nicotera R", "Zicarelli MT", "Urso A", "Presta P", "Deodato F", "Bolignano D", "De Sarro G", "Andreucci M", "Russo E", "Coppolino G"], "date": "2022-01-01T00:00:00Z", "doi": "10.1002/med.21850", "meta_date_publication": "2022 Jan", "meta_volume": "42", "meta_issue": "1", "meta_pages": "629-640", "score": 50246.62, "text_hl": "From our research analysis, evidence for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as emerging cure for @DISEASE_Polycystic_Kidney_Autosomal_Dominant @DISEASE_MESH:D016891 @@@ADPKD@@@ mainly arise from preclinical studies. ", "citations": {"NLM": "Casarella A, Nicotera R, Zicarelli MT, Urso A, Presta P, Deodato F, Bolignano D, De Sarro G, Andreucci M, Russo E, Coppolino G. Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease. Med Res Rev. 2022 Jan;42(1):629-640. PMID: 34328226", "BibTeX": "@article{34328226, title={Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease.}, author={Casarella A and Nicotera R and Zicarelli MT and Urso A and Presta P and Deodato F and Bolignano D and De Sarro G and Andreucci M and Russo E and Coppolino G}, journal={Med Res Rev}, volume={42}, number={1}, pages={629-640}}"}}, {"_id": "33439105", "pmid": 33439105, "title": "Metformin slows liver cyst formation and fibrosis in experimental model of polycystic liver disease.", "journal": "Am J Physiol Gastrointest Liver Physiol", "authors": ["Sato Y", "Qiu J", "Hirose T", "Miura T", "Sato Y", "Kohzuki M", "Ito O"], "date": "2021-04-01T00:00:00Z", "doi": "10.1152/ajpgi.00120.2020", "meta_date_publication": "2021 Apr 1", "meta_volume": "320", "meta_issue": "4", "meta_pages": "G464-G473", "score": 50245.625, "text_hl": "After 12 wk, liver function, histology, and signaling cascades of @DISEASE_Polycystic_liver_disease @DISEASE_MESH:C536330 @@@PLD@@@ were examined in the groups. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ did not affect the body weight or liver weight, but it reduced @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@liver cyst formation@@@, cholangiocyte proliferation, and @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@fibrosis@@@ around the @<m>DISEASE_Cysts</m> @DISEASE_MESH:D003560 @@@cyst@@@. ", "citations": {"NLM": "Sato Y, Qiu J, Hirose T, Miura T, Sato Y, Kohzuki M, Ito O. Metformin slows liver cyst formation and fibrosis in experimental model of polycystic liver disease. Am J Physiol Gastrointest Liver Physiol. 2021 Apr 1;320(4):G464-G473. PMID: 33439105", "BibTeX": "@article{33439105, title={Metformin slows liver cyst formation and fibrosis in experimental model of polycystic liver disease.}, author={Sato Y and Qiu J and Hirose T and Miura T and Sato Y and Kohzuki M and Ito O}, journal={Am J Physiol Gastrointest Liver Physiol}, volume={320}, number={4}, pages={G464-G473}}"}}, {"_id": "41020837", "pmid": 41020837, "title": "Metformin as a Disease-Modifying Agent in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review of Preclinical and Clinical Evidence.", "journal": "Curr Issues Mol Biol", "authors": ["Maciejczyk A", "Niemczyk M"], "date": "2025-09-03T00:00:00Z", "doi": "10.3390/cimb47090715", "meta_date_publication": "2025 Sep 3", "meta_volume": "47", "meta_issue": "9", "meta_pages": "", "score": 50245.344, "text_hl": "In preclinical studies, it reduced @<m>DISEASE_Cysts</m> @DISEASE_MESH:D003560 @@@cyst@@@ formation, improved kidney structure, and decreased @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@. ", "citations": {"NLM": "Maciejczyk A, Niemczyk M. Metformin as a Disease-Modifying Agent in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review of Preclinical and Clinical Evidence. Curr Issues Mol Biol. 2025 Sep 3;47(9):. PMID: 41020837", "BibTeX": "@article{41020837, title={Metformin as a Disease-Modifying Agent in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review of Preclinical and Clinical Evidence.}, author={Maciejczyk A and Niemczyk M}, journal={Curr Issues Mol Biol}, volume={47}, number={9}}"}}, {"_id": "32566257", "pmid": 32566257, "pmcid": "PMC7295815", "title": "Metformin effectively treats Tsc1 deletion-caused kidney pathology by upregulating AMPK phosphorylation", "journal": "Cell Death Discov", "authors": ["Fang Y", "Li F", "Qi C", "Mao X", "Wang F", "Zhao Z", "Chen JK", "Zhang Z", "Wu H"], "date": "2020-06-15T00:00:00Z", "doi": "10.1038/s41420-020-0285-0", "meta_date_publication": "2020", "meta_volume": "6", "meta_issue": "", "meta_pages": "52", "score": 50243.715, "text_hl": "Data were from 4 weeks of age @SPECIES_10090 @@@mice@@@ (n = 5-6 each per group) and expressed as means +- SEM, **P < 0.01. e Higher-magnification light microscopy demonstrated that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ decreased @<m>DISEASE_Cysts</m> @DISEASE_MESH:D003560 @@@renal cysts@@@, as well as suppressed enlarged proximal tubules in Tsc1ptKO @SPECIES_10090 @@@mice@@@, compared with vehicle-treated group. ", "citations": {"NLM": "Fang Y, Li F, Qi C, Mao X, Wang F, Zhao Z, Chen JK, Zhang Z, Wu H. Metformin effectively treats Tsc1 deletion-caused kidney pathology by upregulating AMPK phosphorylation Cell Death Discov. 2020;6():52. PMID: 32566257", "BibTeX": "@article{32566257, title={Metformin effectively treats Tsc1 deletion-caused kidney pathology by upregulating AMPK phosphorylation}, author={Fang Y and Li F and Qi C and Mao X and Wang F and Zhao Z and Chen JK and Zhang Z and Wu H}, journal={Cell Death Discov}, volume={6}, pages={52}}"}}, {"_id": "35748097", "pmid": 35748097, "pmcid": "PMC9527591", "title": " PF-06409577 inhibits renal cyst progression by concurrently inhibiting the mTOR pathway and CFTR channel activity", "journal": "FEBS Open Bio", "authors": ["Su L", "Yuan H", "Zhang H", "Wang R", "Fu K", "Yin L", "Ren Y", "Liu H", "Fang Q", "Wang J", "Guo D"], "date": "2022-10-01T00:00:00Z", "doi": "10.1002/2211-5463.13459", "meta_date_publication": "2022 Oct", "meta_volume": "12", "meta_issue": "10", "meta_pages": "1761-1770", "score": 50242.668, "text_hl": "Indeed, a previous study reported that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could effectively inhibit @<m>DISEASE_Cysts</m> @DISEASE_MESH:D003560 @@@renal cyst@@@ growth in two @SPECIES_10090 @@@mouse@@@ models of @DISEASE_Polycystic_Kidney_Autosomal_Dominant @DISEASE_MESH:D016891 @@@ADPKD@@@. ", "citations": {"NLM": "Su L, Yuan H, Zhang H, Wang R, Fu K, Yin L, Ren Y, Liu H, Fang Q, Wang J, Guo D.  PF-06409577 inhibits renal cyst progression by concurrently inhibiting the mTOR pathway and CFTR channel activity FEBS Open Bio. 2022 Oct;12(10):1761-1770. PMID: 35748097", "BibTeX": "@article{35748097, title={ PF-06409577 inhibits renal cyst progression by concurrently inhibiting the mTOR pathway and CFTR channel activity}, author={Su L and Yuan H and Zhang H and Wang R and Fu K and Yin L and Ren Y and Liu H and Fang Q and Wang J and Guo D}, journal={FEBS Open Bio}, volume={12}, number={10}, pages={1761-1770}}"}}]}